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Background: Extracellular double-stranded DNA participates in various processes in an organism. Here we report
the suppressive effects of fragmented human double-stranded DNA along or in combination with cyclophosphamide
on solid and ascites grafts of mouse Krebs-2 tumor cells and DNA preparation on human breast adenocarcinoma cell
line MCF-7.
Methods: Apoptosis and necrosis were assayed by electrophoretic analysis (DNA nucleosomal fragmentation) and
by measurements of LDH levels in ascitic fluid, respectively. DNA internalization into MCF-7 was analyzed by flow
cytometry and fluorescence microscopy.
Results: Direct cytotoxic activity of double-stranded DNA (along or in combination with cyclophosphamide) on a
solid transplant was demonstrated. This resulted in delayed solid tumor proliferation and partial tumor lysis due to
necrosis of the tumor and adjacent tissues. In the case of ascites form of tumor, extensive apoptosis and secondary
necrosis were observed. Similarly, MCF-7 cells showed induction of massive apoptosis (up to 45%) as a result of
treatments with double-stranded DNA preparation.
Conclusions: Double-stranded DNA (along or in combination with cyclophosphamide) induces massive apoptosis
of Krebs-2 ascite cells and MCF-7 cell line (DNA only). In treated mice it reduces the integrity of gut wall cells and
contributes to the development of systemic inflammatory reaction.
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Double-stranded extracellular DNA fragments of either
exogenous or endogenous origin act as key regulators
and active participants of various processes in an organism.
First, exogenous nucleic acids serve as pathogen-associated
molecular patterns and activate different cells of immune
system geared towards pathogen elimination. Endogenous
extracellular double-stranded DNA (dsDNA) may also* Correspondence: labmolbiol@mail.ru
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unless otherwise stated.function as an activator of adaptive immune response [1-8].
Additionally, endogenous extracellular dsDNA present
in the blood plasma and interstitial fluids reflects the
functional state of an organism and may serve as a
marker of ongoing disease [9-12]. It is well-established
that dsDNA is an inducer of autoimmunity and that it
may also mediate the bystander effect [13-19]. Systemic
inflammatory reaction and sepsis are normally accom-
panied with rapid increase in serum DNA concentration
[18,20-24]. On a cellular level, dsDNA fragments reaching
the cell internal comparments may participate in a num-
ber of processes. First, the very presence of extracellulartral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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induces DNA repair [25-27]. Under certain conditions,
dsDNA fragments may actively interfere with accurate
progression of DNA repair [28-30]. DsDNA fragments
delivered to the cytoplasm of somatic cells are detected by
a variety of cytosolic sensors thereby launching the first
steps of adaptive immune response [31-35]. Data are also
available demonstrating that exogenous circulating DNA
may participate in transport of genetic material from
destroyed cancer cells to normal cells, thereby mediating
their malignant transformation. A special term, “genome-
tastasis”, was coined to describe this phenomenon [36,37].
Nucleic acids, including dsDNA, have been shown to be
present in exosomes. Such nucleic acids were hypothe-
sized to serve as an “internal standard” of the organism
functional state, which helps certain cell populations
tune in their physiological and molecular processes.
Presently, mounting evidence suggests that extracellular
nucleic acids, including dsDNA, in fact represent a
novel regulatory module controlling a plethora of cellu-
lar processes [38-48].
Our studies establish for the first time the direct cyto-
toxic activity of dsDNA preparation administered alone
or in combination (and in synergy) with a cytostatic drug
cyclophosphamide (CP) against cancer cells of various
origin. This treatment results in massive apoptosis of
tumor cells, which is however uncoupled from internal-
ization of dsDNA fragments into the cell interior.
Results
Motivation of the study
Our earlier studies of how extracellular exogenous dsDNA
contributes to the activation of professional properties
of antigen-presenting dendritic cells and establishment
of anticancer CD8 + −mediated antitumor immunity
reported a number of puzzling effects unrelated to the
development of immune response. Namely, we observed
significantly suppressed proliferation of tumors grafts in
either solid or ascites forms [49-54]. We found that
upon consecutive treatment with CP and dsDNA, there
is a short period of time after CP injection when admin-
istration of dsDNA causes direct toxicity to the cells of
engrafted tumor. Three formally plausible explanations
could account for such an effect resulting in delayed
growth of engrafted tumors. First, this could occur due to
selective DNA internalization by cancer cells, followed
by interference with repair of CP-induced interstrand
cross-links (ICLs), essentially in the same way as it was
observed for mouse hematopoietic stem cells [28,29].
Second, this could be caused by a yet unknown form of
interaction between DNA and an eukaryotic cell which
occurs without dsDNA internalization (analogous to the
bystander effect) [19,55]. Finally, the effector of direct
tumor toxicity could be not the dsDNA preparationitself, but rather cross-linked dsDNA. One of the treat-
ment regimens was consistent with such a possibility, as
it involved simultaneous presence of extracellular
dsDNA fragments and a CP metabolite, phosphoramide
mustard, in the organism. The latter compound is an
alkylating metabolite of CP, which is formed upon CP
hydrolysis in the liver, and so it may induce formation
of ICLs in dsRNA and dsDNA molecules. Given that
phosphoramide mustard easily gets transported to all
the cells of an organism, one can expect that injected
dsDNA will be inevitably cross-linked.
Pilot experiments that defined the study design
To better understand the mechanism of how CP + dsDNA
treatment suppresses tumor graft growth, we proceeded
to perform a series of pilot experiments. First, using a solid
form of Krebs-2 tumor, we directly evaluated the synergis-
tic toxicity of CP and human dsDNA (hDNA). DNA was
injected directly into tumors at 1–12 h and 18–30 h time-
points post-CP (as was described in [28]), so as to match
the timing of ICL repair phases, NER and homologous re-
combination. Experiments were performed multiple times
and results from a typical experiment including pathology
analysis of mouse organs and tissues are presented below.
During the 9 days after the therapy, the tumors would stop
growing and remained ~2.0 cm3 (CP + hDNA), or pro-
gressed from ~2.0 to 4.0 cm3 upon CP + saline treatment
(Figure 1А). Mice treated with just hDNA consistently dis-
played lysis of tumor graft and adjacent tissues, which was
accompanied by profuse purulent discharge. It must be
emphasized that significant mortality was observed in the
CP + hDNA groups of mice bearing solid Krebs-2 trans-
plants during the days 1–4 following the treatment (data
not shown). These observations are consistent with
massive histolysis at injection sites, first and foremost with
decay of tumor tissue accompanied with intoxication that
is ultimately lethal.
To approach the possible causes of these destructive
effects and to understand why experimental animals
would succumb almost synchronously, we first per-
formed pathology and morphology analysis of organs
and tumor foci from animals treated with CP + saline or
CP + hDNA. Animals with a tumor of ~2.5 cm3 received
CP injection (200 mg/kg), which was followed with 12
injections of hDNA (250 mkg each) or saline every hour,
straight into the tumor graft. On day 3 after these treat-
ments, one animal was sacrificed from both experimen-
tal and control groups, two more and one more were
sacrificed on days 4 and 5. All animals from the experi-
mental group were in moribund state.
Pathology report of mouse necropsies
All experimental animals displayed pronounced patho-
logical changes in the liver and spleen. Focal degeneration
Figure 1 (See legend on next page.)
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Figure 1 Effects of CP and/or hDNA treatments on Krebs-2 tumor cells propagated as ascites or solid tumors. А) Growth of solid Krebs-2
tumors in animals treated with CP followed with hDNA or saline injections (n = 4). Time of CP injection is denoted by an arrow. B) Representative
images of tumor sections after the treatments: 1 – tumor tissue is clearly distinct from the dermal elements and subcutaneous tissue, as it displays
pronounced cellular atypia and aggressive growth (arrow); 2 – tumor cell fibers interleave with fragments of muscle fibers (arrows); 3 – massive
necrosis of tumor tissue (arrow). С) Percentage of surviving animals bearing Krebs-2 ascites and treated with hDNA, CP + saline or CP + hDNA 1–12
hours post CP injection (number of experiments, n = 3-5). Survival in the groups was compared daily. D) Changes in weight of animals engrafted with
Krebs-2 ascites after CP + saline or CP + hDNA 1–12 or 18–30 hours post CP injection. Initial weight of animals was taken as 100%. Average
weight of mice is shown (n = 8). Е) Comparison of ascites weight in animals treated with CP + saline vs CP + hDNA (1–12 or 18–30 hours post
CP treatment), on day 8 after the treatments (n = 8).
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observed in the liver. Inflammatory reaction generally
manifested as increased numbers of lymphocytes in
blood capillaries. In several cases, we observed forma-
tion of predominantly round cell infiltrations around
portal area and central veins. No evidence of liver par-
enchyma necrosis was found in any of the animals. All
mice displayed marked reduction in size of spleen
lymphoid follicles.
Notably, moderate dystrophy of myocardium was
evident in a single tumor-bearing mouse treated with
CP + hDNA and one more mouse from the same group
had a subepicardial metastasis-like lesion. The rest of
the experimental animals displayed no pathological
changes in myocardium or other organs.
Tumor tissue was clearly distinct from the surround-
ing dermal elements and subcutaneous tissue due to
its pronounced cellular atypia and aggressive growth
pattern. The latter phenotype was particularly notable
where fibers of tumor cells interleaved with fragments
of muscle fibers. Massive necrosis of tumor tissue was
particularly strong in the group of CP + hDNA-treated
animals consistent with their symptoms. Polymorpho-
cellular infiltrate formed a thin border between the
tumor and healthy tissues (Figure 1B, Additional file 1).
Pathology-wise, the highest organ toxicity was observed
in animals treated with a combination of CP and multiple
ICL-hDNA injections (Additional file 1).
To avoid the lethality concern and to determine the
most efficacious schedule of CP + hDNA administration,
we performed a series of experiments wherein mice with
tumor grafts of just ~0.25 cm3 were treated. This modi-
fication to the treatment protocol resulted in that lysed
tumor material was effectively cleared by immune cells,
thereby avoiding lethal toxicity. The highest degree of
cytoreductive activity was observed when mice were
treated with hDNA during the period of 1–12 h post-CP
injection (data not shown).
Solid Krebs-2 tumors are densely cellularized; they are
typically enclosed in a connective tissue capsule and lack
extensive capillary network. Clearly then, delivery of any
high-molecular weight molecules (such as human dsDNA)
to such tumors is very inefficient and non-uniform [49]
This obstacle prevented us from directly assessing thetumor response to CP + hDNA therapy and prompted
the development of an alternative model, where the
same Krebs-2 tumor cell line is used, yet it is engrafted
to mice as an ascites form.
We first attempted to quantify regression of ascites in
mice treated with CP or CP + hDNA on days 8–10 after
engraftment. Similarly to what was observed with a solid
tumor model, such animals succumbed rapidly and syn-
chronously. Hence, no statistically significant analysis of
tumor graft size dynamics could be done. Representative
survival data are shown in Figure 1C. Next, we estab-
lished that mice bearing 4–5 day ascites and treated with
CP or hDNA, overall do much better. To illustrate this,
we present the data from one of the experiments which
involved male CC57BR mice who received intraperito-
nially (i.p.) injection of ascites form of Krebs-2 tumor
and then intravenously injected with 200 mg/kg CP on
day 6. Of these mice, one subgroup subsequently re-
ceived 500 mkg/injections of hDNA (i.p. for 12 hours).
The other subgroup was similarly administered the same
hDNA injections, however those were done 18 hours
after CP. Mice from the third subgroup were injected
with saline every two hours throughout 0–30 hrs post
CP injection. Mouse weight dynamics expressed in rela-
tive percentage values is presented in the Figure 1D.
Treatment with hDNA preparation during the first
twelve hours after CP injection (first subgroup) resulted
in a significant delay in proliferation of ascites tumor
grafts. Injections during the period of 18–30 hours post
CP treatment enhanced ascites growth, as compared to
CP + saline and CP + hDNA (1–12) groups (detailed ex-
planation of this effect is presented in [30]).
The effects of treatments were independently assessed
in another arm of this experimental series by measuring
the ascites weight in animals 8 days after the start of
experiment (Figure 1E). We show that treatment with
hDNA 1–12 hours post CP injection results in a statis-
tically significant reduction of ascites weight in treated
animals.
These pilot experiments involving ascites and solid forms
of Krebs-2 tumors indicated four pronounced trends:
1. Very rapid and largely synchronous death of
experimental animals was observed, when mice with
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of CP and hDNA (regardless of whether the tumor
graft was solid or ascitic).
2. Ascites weight decreased and solid tumor tissue
lysed in animals treated with CP and hDNA.
3. The strongest therapeutic effect was found when
animals received hDNA injections during the first
12 hours post CP injection.
4. Under such regimen (CP + hDNA (1–12)),
prolonged regression of ascites growth and delayed
proliferation of solid grafts were observed.
Thus, the experimental design of this study aimed at
developing the strategy that would allow discriminating
the contributions of each of the effects observed and to
pinpoint the possible molecular and physiological mech-
anisms involved. Two major research directions were
considered. The first direction focused on understanding
why experimental animals succumbed so rapidly and
synchronously and why ascites shrank and solid tumors
displayed delayed growth. The second direction of re-
search addressed the question of why prolonged remis-
sion was observed in ascites-bearing animals treated
with CP and hDNA (1–12). Specifically, we analyzed the
effects on Krebs-2 tumor-initiating stem cells, which we
recently described as capable of naturally internalizing
extracellular dsDNA fragments. Most of the experimen-
tal data supporting the role of tumor-initiating stem cells
elimination in the loss of tumorigenic properties of
tumor grafts (and hence in remission of the experimen-
tal animals) are presented in [30].
Comprehensive analysis of pathological processes that
develop in synchronously dying experimental animals
The events observed in our pilot experiments defined
the routes of follow-up studies. All the subsequent ex-
periments used only ascites form of Krebs-2 tumor. We
calculated mouse survival, quantified viable ascitic cells
by FACS, and determined the extent of apoptosis (by
measuring chromatin fragmentation into nucleosomal
ladders). We assessed the degree of necrosis (LDH levels
in ascitic fluid), performed pathology and anatomy ana-
lysis of tissues, organs, tumor foci and peritoneal wall
from ascites-engrafted mice. Additionally, we described
the interplay between the ascites size, treatment regimen
and sterility of ascitic fluid. Multiple replicas were per-
formed for all of these experiments, and the results of
such experiments are presented in the figures. We report
a previously undescribed phenomenon of massive apop-
tosis of Krebs-2 ascites induced by treatment with
hDNA without CP preconditioning. Sampling timepoints
differed between the experiments depending on the
specific goals. The effects of hDNA and ICL-hDNA
were also compared.Experiments performed can be broadly categorized
into two groups. The first set of experiments character-
ized the events occurring in mice upon synergistic action
of CP and hDNA preparations. The second set of experi-
ments focused on events in mice treated solely with
hDNA.
Results of the first set of experiments are summarized
below:
1. When using mice with 9–15 day ascites, the
animals in the groups CP + hDNA (1–12), CP +
hDNA (18–30), CP + ICL-hDNA (1–12) and CP +
ICL-hDNA (18–30) died on days 1–3 after CP
injection. With only 1–2 surviving animals, no
statistical analysis was possible, and no additional
data could be retrieved (Figure 1C).
2. Shrinking of solid or ascites tumors is correlated
with massive, up to 80%, apoptosis of cancer cells
induced by the treatments (Figure 2A,В). Cancer
cell necrosis is also noticeable. Elevated LDH levels
(3-6-fold) are observed across the sampling timepoints
relatively to the initial values (Figure 2C). The timing
of massive apoptosis and surging LDH levels
immediately precede the death of experimental
animals.
3. Pathology analysis suggests that when ascites-bearing
mice are treated with a combination of CP and
hDNA, necrosis is induced in both the target tumor
and the surrounding non-tumor tissues, particularly
in peritoneum. Large-scale destructive changes are
present in the intestinal wall, which may compromise
its integrity thereby affecting its permeability
(Figure 2D). Increased gut wall permeability likely
results in rapid infestation of ascitic fluid by intestinal
bacteria.
4. By day 5, ascites fluid remains sterile. We show that
by days 9–15, 75% of ascites samples are non-sterile
and are infected with bacterial flora. This bacterial
infestation is not due to bacterial contamination of
DNA preparation, as no bacteria are detectable in
10 mg (100 mkl) of hDNA prep (Figure 2E). The
total amount of hDNA received by each mouse in
course of experiments is 6 mg.
5. Combined CP + hDNA treatment leads to infection
of ascitic fluid within 24 hours, and is correlated
with the death of experimental animals. In contrast,
a series of saline injections following CP administration
does not result in instantaneous infection of ascitic
fluid and rapid death of mice.
A second series of experiments, when hDNA-only
injections were done within 12 hours, allowed us to
disentangle the complex picture of events and to uncover
a previously unreported phenomenon:
Figure 2 (See legend on next page.)
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Figure 2 Apoptosis, necrosis and destructive changes in gut cell wall of tumor-engrafted animals under different treatment regimens.
A) Viability of Krebs-2 ascites isolated from animals treated with CP and/or hDNA. Flow cytometry plots are presented, and percent of viable cells
is indicated (top panel). Microscopy analysis of Krebs-2 ascites following different treatments (bottom panel). B) Progression of apoptosis assayed
as the degree of fragmentation of nucleosomal DNA isolated from ascitic fluid (ascites cells removed) on day 3 after CP + hDNA or CP + ICL-hDNA
treatment. Typical apoptotic DNA ladder of nucleosome-size fragments (arrows) is present in DNA from ascitic fluid of treated, but not untreated
animals (control). Numbers 1–3 denote ascitic DNA samples obtained from three individual animals. C) Degree of necrosis as assayed by LDH
levels in ascitic fluid on day 3 after the treatments indicated (P < 0.05, Mann–Whitney U-test, n = 3-6). D) Pathology analysis of several affected
tissues from animals treated with hDNA preparations and CP: 1 – abdominal wall skin: subdermal necrosis focus (arrow), E – epidermis; 2 – magnified
view of necrosis focus: bottom right – subcutaneous tissue (SC), top left – necrotic detritus (arrow); 3 – intestinal mucosa villi appear rounded
as a result of ongoing destructive process (arrow), epithelium is almost entirely gone, stroma appears swelled, with infiltrating lymphocytes
present. Taken together, these features are consistent with a pathomorphology pattern of acute enteritis; 4 – extensive mucosal swelling, remnants of
villi and pronounced inflammatory infiltration with lymphoid cells. Arrow points to sclerotic mucosa (section of normal intestine is shown in Additional
file 1). These features are morphologically compatible with the signs of chronic enteritis. E) Sterility cultures of hDNA preparation and ascites grown in
mice: 1 – 5-day ascites; 2 – 9-day ascites; 3 – hDNA (1 mg total).
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during the course of hDNA-only injections (Figure 1A).
This was accompanied with induced apoptosis of
ascitic cells. Apoptosis with detectable nucleosomal
DNA fragmentation is observed 24 hours after hDNA
injection (Figure 3C1). Increase in LDH levels is
delayed and is first detectable 48 hours post first
hDNA injection (Figure 1B). Notably, at this period
of time we find no evidence of DNA cleavage into
nucleosomal fragments, as it follows from the agarose
gel analysis of DNA isolated from ascites (Figure 3С3).
Clearly, this is consistent with complete disintegration
of chromatin, which is typical for necrotic phase of
apoptosis.
Our data suggest the CP blocks induction of apoptosis
by hDNA preparation, which appears as absence of
nucleosomal ladder that is typical for DNA monotherapy
(data not shown). In contrast, in mice treated with just
CP, the endstage of apoptosis is observed only on day 3
(Figure 2B).
In order to determine whether this new phenomenon
of hDNA-induced massive apoptosis is dependent on a
particular body system, similar experiments were carried
out using ascitic cells isolated from animals and cultured
ex vivo. As it turned out, very similar pattern of induced
apoptosis in ascitic cells is observed. Cell counts went
down when treated with DNA, whereas when ascites
were left untreated, cells counts increased (data not
shown). Furthermore, ex vivo experiments fully
recapitulated the in vivo effect of conversion of apoptotic
DNA (at 24 h) into DNA degradation pattern consistent
with secondary necrosis at 72 h (Figure 3С2, 4).
Induction of apoptosis in MCF-7 cells by human dsDNA
preparation
The phenomenon of massive cell apoptosis was origin-
ally described by our group in experiments on mouse
bone marrow cells: up to 90% of such cells became
apoptotic depending on the DNA substrate used [28,29].These and subsequent experiments established that 1%
and 1-7% of nucleated bone marrow cells and Krebs-2
ascites were hDNA-internalizing [30]. This striking dif-
ference between low percentage of hDNA-internalizing
cells and high percentage of cells undergoing apoptosis
may indicate that apoptosis is not linked directly to hDNA
internalization. Therefore, some alternative mechanism of
apoptosis induction must be in place. We used a third
independent cellular model, MCF-7 cell line, to further
illustrate the phenomenon of massive induction of
apoptosis by hDNA fragments. First, we calculated the
percentage of MCF-7 cells capable of internalizing
extracellular hDNA fragments. Using fluorescence mi-
croscopy and flow cytometry, we established that ~0.2%
MCF-7 cells can internalize TAMRA-labeled Alu frag-
ment upon co-incubated for 1 hour (Figure 4А,В). To
assess the magnitude of apoptosis in MCF-7 cells, these
cells were incubated for different periods of time with
exogenous DNA and apoptosis was induced by addition
of TNF-α. Total DNA was fractionated by gel electro-
phoresis. Then the DNA was extracted from the gel and
quantified. Given that cellular DNA content is known,
this could be translated into the percentage of apoptotic
cells (see Materials and Methods). The results obtained
suggest that the percentage of MCF-7 undergoing apop-
tosis is at least 14.8% and 44.5%, after 3 days of incubation
followed by 48 hours induction and and upon 8 days +
48 h induction, respectively (Figure 4С).
These data prompted us to explore whether dsDNA-
induced induction of apoptosis is also characteristic for
other cell types, − either produced ex vivo or passaged
as cell lines. Three distinct cell types were thus analyzed,
namely mitomycin-treated mouse fibroblasts (feeder cells),
human embryonic kidney 293FT cell line and mouse bone
marrow cells produced ex vivo. We observed that dsDNA
preparation failed to induce apoptosis under these specific
conditions (dsDNA/cell ratio was approximately the same
as in experiments in vivo, 75–150 mg DNA/106 cells) in
feeder cells and HEK 293FT cells. In contrast, mouse bone
Figure 3 Analysis of apoptosis induction in ascitic cells 24 or 72 hours after first hDNA injections. А) Survival of Krebs-2 ascites-engrafted
animals after hDNA or CP + saline treatments. B) LDH levels measured in ascitic fluid collected from hDNA or CP + saline groups of mice (n = 4-5).
C) Electrophoretic separation of DNA isolated from ascitic fluid of mice 24 and 72 hours after injections of hDNA (in vivo) or from culture medium
following 24 or 72 hours incubation of ascites with hDNA (ex vivo) 1 – Control lane shows DNA of untreated Krebs-2 ascites, hDNA lane represents
ascitic fluid DNA isolated 24 hours post direct hDNA injections into ascites; 2 – Ascites – DNA from intact ascites, hDNA- and hDNA + − 24 hour
incubation of Krebs-2 ascites in the absence (−) or presence (+) of hDNA, respectively. Arrows on the hDNA+ lane show characteristic pattern
of nucleosomal fragmentation of chromatin; 3 – hDNA – DNA isolated from ascitic fluid 72 hours after hDNA injections directly into ascites grafts. Arrow
indicates specific DNA band originating from necrotic cells; 4 – hDNA- and hDNA+ − incubation of Krebs-2 ascites for 72 hours in the absence or
presence of hDNA preparation, respectively. By 24 hours, apoptotic pattern is already noticeable, whereas by 72 hours it transitions into the
pattern characteristic of secondary necrosis.
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prominent, as compared to the situation when mice are
injected with dsDNA (data not shown).
Discussion
Causes of death of experimental animals
Our study firmly establishes that death of animals was
caused by a complex contribution of several factors:
presence of well-developed ascites, injection of hDNA,
CP or combination thereof.
We found that large, 10–15 cm3, ascites grown in mice
for 9–15 days compromise the integrity of the gut cell
wall so that intestinal bacteria invade the peritoneal
space. This is accompanied with inflammatory reaction,
as was shown for late ascites by Parsons et al. [56].
Nevertheless, the above-mentioned ascites-induced bac-
terial contamination is relatively subacute, it is spreadacross the treatments and does not kill lab animals
quickly. In contrast, treatment with hDNA or CP +
hDNA greatly stimulates and accelerates the destruction
of intestinal cell wall. Peritoneal and tumor necrotic foci
are formed. Under this scenario, infection of peritoneal
space occurs synchronously and massively in different
animals, which typically takes 2 days following CP and/
or hDNA treatments.
This process is overlayed with the following events
that greatly stimulate decomposition of the tumor and
adjacent tissues and organs. Human DNA, CP or CP +
hDNA treatments induce massive apoptosis of ascitic
cells, with rapid progression into secondary necrosis.
The onset of apoptosis induced by hDNA is distinct
from that of CP-induced apoptosis. The final stage of
hDNA-induced apoptosis (chromatin break-down into
nucleosomal fragments) is clearly detectable by the end
Figure 4 Analysis of hDNA internalization and apoptosis induction in MCF-7 cell line. А) Confocal imaging of TAMRA-labeled Alu DNA
internalization by MCF-7 cells after 10, 40, 55 and 80 minutes of co-incubation. В) Internalization of TAMRA-labeled Alu DNA by MCF-7 cells
(flow cytometry analysis): 1 – control cells without DNA; 2 – cells incubated with TAMRA-labeled DNA for 1 hour. С) Nucleosomal ladder formed
by DNA isolated from MCF-7 cells which were cultured with exogenous hDNA and induced by TNFα to undergo apoptosis. 3 d, 8 d denote 3
and 8 days of co-incubation with DNA, accordingly; 24 h and 48 h indicate the duration of TNFα-induced apoptosis. Arrows point to the typical
DNA bands found upon apoptotic DNA defragmentation.
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contrast, is apparent on day 3 after CP injection. No
apoptosis is observed at this time in ascitic fluid upon
hDNA-only injection. Significant increase in LDH levels
and complete degradation of cellular DNA are typical
for this stage, which is consistent with necrotic cellular
lysis. Therefore, two distinct mechanisms for apoptotic
cell death of ascites are at place, differing in the timing
of the final stage of apoptosis.
CP-induced apoptosis is well characterized experimen-
tally, and is associated with aberrant mitosis caused by
error-prone repair of double-stranded breaks. It appears
as a nucleosomal DNA ladder on days 3–4 after CP
injection [57,58].Molecular underpinnings of hDNA-induced apoptosis
still await detailed experimental analysis. Yet, we specu-
late that the nature of these effects may be similar to the
bystander effect. Bystander effect is known to result
from oxidative stress, activation of caspases and DNA-
sensing receptors [19,59,60]. Extracellular dsDNA has
been demonstrated to relay the signal to bystander cells
in the following sequence of events. Free radicals in-
duced by gamma-radiation result in primary oxidative
stress which leads to apoptosis of irradiated cells. DsDNA
fragments liberated from such apoptotic cells interact
with DNA-binding receptors of bystander cells. This in
turn activates signaling pathways boosting production
of reactive oxygen and nitrogen species (in the context
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tive stress leading to apoptosis of bystander cells, which
takes 24 hours [19].
Whatever the exact mechanism, the magnitude of
this effect prevents the specialized cells of immune
system from clearing the peritoneal space from excess
of apoptotic bodies. By day 2 following DNA treat-
ment, and by day 4 post CP treatment, secondary
necrosis of ascitic cells is well discernible [61-63],
which leads to rapid progression into systemic inflam-
matory reaction [22,62,64-66]. This generalized necro-
sis may be further enhanced by lymphocyte necrosis,
which is caused by the release of nucleosomes from
apoptotic bodies [67].
Thus, the death of mice is caused by two major de-
structive processes. In the presence of a well-developed
ascites and upon the combined CP and hDNA treat-
ment, the barrier function of intestinal cell wall is com-
promised catastrophically quickly, which progresses into
bacterial contamination of ascitic fluid and general body
sepsis. This effect is accompanied with massive apoptosis
and secondary necrosis of ascitic cells, which accelerates
and boosts necrosis in peritoneum and gut wall, thereby
promoting infection. Massive necrosis culminates in a
full-blown inflammatory reaction. The range of patho-
logical changes in the organism of experimental animals
shares many common features with both systemic in-
flammation response syndrome and sepsis known from
clinical practice [22,65,66]. In this respect, this system
may become a useful model to explore treatment modal-
ities for sepsis, which is frequently a lethal condition.
Apoptosis of MCF-7 cells and general conclusion on the
phenomenon of induced apoptosis
Using a third distinct model, MCF-7 cells, our experi-
ments demonstrated induction of massive apoptosis
by fragmented hDNA. Depending on the duration of
specific treatments, up to 44% of MCF-7 cells may
undergo apoptosis. In the three cell types tested (mouse
bone marrow cells, Krebs-2 ascites and MCF-7 cell line),
0.2-7% of cells were shown to internalize hDNA. Yet,
the percentage of cells becoming apoptotic in these cell
populations ranged between 40 and 90%. Two possi-
bilities may account for this effect. First, the hDNA-
internalizing cells may secrete specific factor(s) that
launch apoptotic signaling in the neighboring cells.
Alternatively, and somewhat more likely, the DNA
fragments could be recognized by specific cytoplasmic
sensors/receptors harboring “death domains” that in
turn induce apoptosis via mitochondrial pathway.
In our additional experiments on different cell lines,
nucleosomal fragmentation of chromatin was detectable
in only a subset of cell lines tested. Specifically, no
apoptosis could be detected in HEK 293 FT cell line. Incontrast, mouse bone marrow cells underwent apop-
tosis both in vivo [28] and upon culturing ex vivo. No
microscopically detectable apoptosis was observed in
mouse and human DCs produced ex vivo [51-53,68,69].
Taken together, these data suggest that dsDNA-induced
cell apoptosis is not a universal feature of all cells, and its
induction depends on the biology of specific cell type
tested.
Conclusions
The present study demonstrates that hDNA, CP or CP
+ hDNA treatments accelerate the destruction of intes-
tinal cell wall in animals with late ascites. This is due to
massive apoptosis of ascites cells followed by secondary
necrosis by day 2 for hDNA and by day 4 for CP treat-
ment, which results in systemic inflammatory reaction
and body sepsis in experimental mice. MCF-7 cells
treated with hDNA preparation likewise demonstrate
extensive apoptosis. There are two main plausible
mechanisms underlying the effect obtained, namely the
“bystander effect” and specific recognition of DNA frag-
ments by cytoplasmic sensors, but the exact nature of
the processes involved still remains to be determined.
Methods
Lab animals
We used 2-8-month old CBA/Lac, CC57BR and C57Bl
mice strain bred in the Institute of Cytology and Genet-
ics, SB RAS. Animals were grown in groups of 5–10
mice per cage with free access to food and water. All
experiments were performed in accordance with proto-
cols approved by the Animal Care and Use Committee
of the Institute of Cytology and Genetics.
Tumor model
Murine Krebs-2 tumor model was used. To obtain asci-
tes, Krebs-2 cells were diluted 1:10 in 200 μl of normal
saline and inoculated i.p. (~2 × 106 cells). To obtain solid
tumors, Krebs-2 cells were engrafted intramuscularly
into the right hind leg in 100 μl of RPMI-1640 or PBS.
In course of experiments, as soon as tumors became
palpable (about 7 days following the inoculation), they
were measured every 1–2 days with calipers, and tumor
volume was calculated as follows: volume = length ×
width × height.
Injection of CP and exogenous DNA preparations
I.p. or intravenously injections of a cytostatic drug CP
were administered to mice at a dose of 100 or 200 mg/kg
body weight. Next, depending on the specific experimental
design, the preparations of fragmented human DNA
(hDNA) or nitrogen mustard-treated DNA (ICL-hDNA)
were injected i.p. or directly into the solid tumor at
0.5 mg/injection. The following injection schedules
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tion (i.e. a total of 6 mg hDNA prep/mouse). As a control,
an equal volume of normal saline (200 μl/injection) was
used. hDNA injection into solid tumor was done into
multiple sites of a tumor during each injection.
Analysis of apoptotic degradation of Krebs-2 ascites cells
Apoptotic degradation of cells was analyzed via agarose
gel electrophoretic separation of DNA isolated from cells
or ascitic fluid.
Isolation of DNA from ascitic fluid
Post-treatment ascites were collected and centrifuged at
400 g (Eppendorf 5810 R), at 4°С for 5 minutes. EDTA
(Sigma) and proteinase K (Medigen) were added to 500
mkl of supernatant to a final concentration of 0.5% and
100 mkg/ml, respectively, and samples were incubated
for 1 hour at 58°С. Next, an equal volume of phenol-
chloroform (1:1) was added, gently mixed and centri-
fuged at room temperature at 3200 g (Eppendorf 5810
R) for 10 minutes. Upper aqueous phase was transferred
into new tubes and re-precipitated by adding 0.1 volume
of 3 M NaAc and 0.6 volumes of isopropanol. The
cloudy pellet was left to form on ice for 10 minutes and
spun down at 4°С, 3200 g, 15 minutes. Supernatant was
decanted, the pellet was washed with 70% ethanol and
dissolved in 50–100 mkl autoclaved water.
Isolation of DNA from ascites
The collected ascites were washed in 1 ml of PBS
(Medigen), and centrifuged at 400 g (Eppendorf 5810 R),
4°С for 5 minutes. Cell pellet thus obtained was resu-
pended in 2 ml PBS, EDTA was added to 20 mM,
followed by SDS to 1% and proteinase K to 200 mkg/ml.
The suspension was incubated for 2 hours at 58°С and
nucleic acids were phenol-chloropform (1:1) extracted
as above. After re-precipitation and washes, the pellet
was dissolved in 150 mkl water.
Quantification of LDH levels in ascitic fluid
Ascites were collected on day 3 following the treatments
and cells were pelleted by centrifugation at 400 g at 4°С
for 5 minutes. Supernatants (50 μl) were transferred into
clot activator vials and sent out for analysis at Siblabservis,
Ltd (Novosibirsk, Russia).
TAMRA labeling of human Alu repeat DNA
DNA was labeled using PCR. PCR template was human
Alu repeat material cloned in pUC19, this repeat encom-
passed the start and the end of tandemly repeated AluJ
and AluY (NCBI: AC002400.1, 53494–53767). Standard
M13 primers were used for amplification. PCR purifica-
tion was done by phenol-chloroform extraction followed
by ethanol precipitation using ammonium acetate as asalt. DNA concentration and incorporation of dUTP-
TAMRA were measured using Nanodrop (Eppendorf)
and calculated by comparing the signal before and after
PCR re-precipitation.
DNA preparation
Human DNA preparations were isolated from placentas
of healthy women using a phenol-free method. DNA
was fragmented in an ultrasonic disintegrator at a fre-
quency of 22 kHz to obtain a mixture of DNA fragments
with a size of 200 to 6000 bp. DNA preparations were
dissolved in saline and stored at −20°C. This is a phar-
macopieal drug (Registration certificate Medical Drugs
of Russia No. 004429/08 of 09.06.2008) and is manufac-
tured under a trademark of Panagen, Ltd.
Preparation of nitrogen-mustard cross-linked DNA
preparation
Cross-linked human DNA (ICL-hDNA) was obtained by
incubating 500 mg hDNA in a reaction mixture of
200 mM sodium-phosphate buffer, pH 7.4, 400 mkM
mechlorethamine (Merck) in a volume of 1 L adjusted
with water for 24 hours at room temperature [70,71].
Next, the DNA was re-precipitated by addition of
NaAc pH 5.3 to final concentration of 0.3 M and 0.6 V
isopropanol and dissolved in 1 L of water. Cetavlon
(Serva) was added to 2%, and the sample was spun down
at 15000 g (Beckman J2-21) for 40 minutes at room
temperature. Supernatants were decanted and centrifuge
tubes were dried up-side-down for 5 minutes on filter
paper. The pellets were mixed with 200 ml 5% cetavlon
and centrifuged at 25000 g, for 30 minutes at room
temperature. Supernatants were removed by decanting
and tubes were air-dried for 5 minutes on a filter paper.
In order to assure that no phosphate buffer remains,
cetavlon treatment was repeated for one more time.
Air-dried pellet was completely dissolved in 150 ml
ethanol by incubating at 65°С for 40 minutes. Then,
3 ml 5 M NaCl was added and samples in centrifuge
flasks were put at −20°C overnight. The samples were
centrifuged at 25000 g, 20 minutes at +4°С, and the
pellet was carefully dried by placing the tube on a filter
paper. The pellet was mixed again with 200 ml of ice-cold
ethanol, centrifuged and air-dried as above, followed by
drying for 10 minutes at 37°С. DNA pellet was dissolved
in 45 ml of bi-distilled water. The yield of nitrogen
mustard-treated human DNA was 486 mg, with size range
of DNA fragments remaining unchanged.
Histopathology analysis of mouse tissues and organs
Pieces of tissues, organs, tumor foci and peritoneal wall
from mice engrafted with ascites were fixed in 4%
formaldehyde, dehydrated in a graded series of alcohols,
cleared in xylol and embedded in paraffin. 5 μm thick
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AxioImager ZI microscope (Zeiss) was used for imaging.
Sterility culture
Ascitic material collected from the treated animals
was centrifuged at 400 g (Eppendorf 5810 R), 4°С for
5 minutes. Supernatant was spread on agar plates. Each
plate contained a mixture of ascitic fluid from 5
animals (250 mkl total).
MCF-7 cell culture
Human breast adenocarcinoma (MCF-7) cells were
obtained from the Institute of Cell Cultures, SRC VB
Vector (Koltsovo, Novosibirsk oblast, Russia) and tested
for the absence of mycoplasma contamination. Authenti-
city of the culture was confirmed by DNA fingerprinting
and cytological examination. The cells were cultivated in
the RPMI-1640 medium supplemented with 10 mM
L-glutamine and 50 μg/ml streptomycin (Sigma) at 37°C
in the presence of 5% fetal bovine serum (Biolot) in an
atmosphere of 5% CO2 at 70-100% confluency.
Fluorescence microscopy and flow cytometry analysis of
internalization of TAMRA-labeled hDNA by MCF-7 cells
MCF-7 cell culture was grown to 80-90% confluence.
0.02 mkg TAMRA-labeled human Alu DNA was added
to 1.8 × 106 MCF-7 cells (ø40 mm Petri dish) and imme-
diately placed under laser scanning microscope LSM 510
META (Zeiss).
5.4 × 106 MCF-7 cells were incubated with 0.06 mkg
TAMRA-labeled human Alu DNA for 1 hour at 37°C.
Then the cells were trypsinized and washed once with
PBS. Internalization of labeled DNA was assayed usingТable 1 Analysis of MCF-7 cells becoming apoptotic following
induced to apoptosis with TNFa
DNA fragment Concentration, ng/mkl Weight, mkg Le
1,0 15.3 0.77
1,1 18.3 1.83
1,2 10.6 0.53 720
1,3 13.6 0.68 540
1,4 19.1 0.96 360




2,2 4.2 0.21 720
2,3 3.4 0.17 540
2,4 8.1 0.41 360
2,5 11.7 0.59 180
Lane 2 8.4
1,0, 2,0 – genomic DNA, 1,2-1,5, 2,2-2,5 – four most fast-migrating nucleosomal fragflow cytometer BD FACS Aria (BD, USA), with cells not
incubated with DNA serving as a negative control.
Isolation and analysis of apoptotic DNA
To analyze the DNA fragmentation during apoptosis,
MCF-7 cells were incubated for 24 h or 48 h at 37°C in
the presence of 0.1 μg/ml tumor necrosis factor-alpha
(TNF-α) and 10 μg/ml cycloheximide in RPMI-1640
supplemented with 10 mM L-glutamine, 50 μg/ml
streptomycin, and 5% FBS. For DNA isolation, the cells
resuspended in water were supplemented with SDS to
1%, EDTA to 20 mM, and proteinase K to 200 μg/ml
and incubated at 60°C for 1 h. DNA was precipitated
with isopropanol, dissolved in water, again adjusted with
EDTA to 20 mM and proteinase K to 200 μg/ml and in-
cubated at 60°C for 3 h. The mixture was supplemented
with 500 μg/ml ribonuclease and kept for 60 min at 37°C.
The specimens were analyzed in 2% agarose gel by
electrophoresis.
To assess the progression of apoptosis, four most
prominent DNA bands of apoptotic ladder (180, 360,
540 and 720 bp) were excised and gel-purified. DNA
concentration was measured using Nanodrop (Eppen-
dorf). These DNA fragments represent the final products
of DNAse-mediated degradation of genomic DNA. The
weight of these DNA fragments equal to the weight of a
single cell genome can be considered as a weight of
DNA of a single cell completely hydrolyzed down to
these four monomers. Hence, the weight of these four
DNA bands divided by the 2n genome weight (~6 pg)
translates into the minimal number of cells that achieved
complete apoptotic degradation, i.e. it corresponds to the
minimum % apoptosis (Table 1).culturing with fragmented exogenous human DNA and











ments, 1,1, 2,1 – larger fragments of apoptotic DNA.
Alyamkina et al. Cancer Cell International  (2015) 15:32 Page 13 of 14Statistical analysis
Students’ t-tests were used to determine the significance
of differences in tumor growth, and average survival
between the mouse groups and the controls. All results
are expressed as mean ± SEM.
Absence of SEM “whiskers” on the plots denotes that
only one or two mice survived to this experimental time
point, thereby precluding statistical analysis. Neverthe-
less, these datapoints are presented, as they demonstrate
the maximum toxicity effect of the treatments performed.
Statistical significance of differences in LDH levels was
assessed using non-parametric statistics and Mann–
Whitney U-test.
Additional file
Additional file 1: Pathomorphology analysis of mouse organs and
tissues.
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